Seattle, Washington May 9, 2019 (Issuewire.com) - The Global Blood Gas Analyzers Market, by Product Type (Bench Top and Portable), by Application (Anesthesia, Cardiovascular Surgery, ICU, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 594.6 million in 2017 and is projected to exhibit a CAGR of 5.5% over the forecast period (2018 - 2026), as highlighted in a new report published by Coherent Market Insights.
Major players operating in the global blood gas analyzers market include Abbott Laboratories, Alere, Inc., Bayer AG, Dalko Diagnostics, GE Healthcare, Instrumentation Laboratory, Nova Biomedical, Radiometer, Roche Diagnostics, Siemens Healthcare, and Sphere Medical
Request Sample Copy of This Report @ https://www.coherentmarketinsights.com/insight/request-sample/2603
In emergency and critical care settings blood tests, which specifically include the provision of blood gases can improve clinical decision-making and patient outcomes. Several hospitals have implemented bedside testing for blood gases either on an institutional level or more commonly, in selected patient care settings such as pulmonary unit, emergency department, and neonatal intensive care. This reduces operational cost and improves staff efficiency, which may further enhance clinical outcomes.
Technological advancements in blood gas analyzers such as easy to operate and ready to use features are boosting their adoption in medical settings. Increasing demand for Point-of-Care (PoC) testing leads to fast and accurate blood gas analysis. Key market players are focused on developing portable blood gas analyzers in order to increase usability and comfort.
For instance, in April 2018, Radiometer Limited launched its CE-marked point-of-care tests for creatinine and urea, which is the latest additions to the ABL90 FLEX PLUS blood gas analyzer’s test menu. The versatile ABL90 FLEX PLUS is considered to be the only compact blood gas analyzer in the market to offer such an extensive range of critical care parameters including blood gas, electrolytes, metabolites, and co-oximetry.
Moreover, in 2015, Sphere Medical, launched arterial blood gas analyzer, Proxima System in Europe. The device delivers efficient PoC testing as it offers frequent blood gas measurements at the patient’s bedside. This facilitates effective and timely clinical decisions for proactive critical care.
Browse 32 Market Data Tables and 21 Figures spread through 153 Pages and in-depth TOC on "Blood Gas Analyzers Market, by Product Type (Bench Top and Portable), by Application (Anesthesia, Cardiovascular Surgery, ICU, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026"
Request For Discount On This Report @ https://www.coherentmarketinsights.com/insight/request-discount/2603
Key Takeaways of the Blood gas analyzers Market:
The global blood gas analyzers market is expected to expand at a CAGR of 5.5% during the forecast period, owing to the increasing demand for PoC testing.
Among product type, the portable blood gas analyzer segment is expected to witness the highest growth rate in 2026, due to the ease of use provided by these devices in comparison to bench top products
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Media Contact
Coherent Market Insights sales@coherentmarketinsights.com 2067016702 Mr. Shah https://www.coherentmarketinsights.com
